This animation explores progress in the development of oral anticoagulants that target components of the blood coagulation cascade to inhibit blood clotting in high-risk patients.

LEEDS, England--(BUSINESS WIRE)--LUNAC Therapeutics (LUNAC), a UK based drug discovery company focused on the identification and development of advanced anticoagulants with minimal bleeding risk, ...

Blood coagulation is a balancing act. Too much clotting can lead to strokes. But not enough clotting can lead to uncontrolled bleeding. That balance is particularly important for patients with ...

The multibillion-dollar worldwide market for injectable antithrombotic drugs (including anticoagulants and antiplatelet agents) will continue to grow as minimally invasive surgical interventions to ...

Blood coagulation involves a delicate balancing act. It must occur immediately in response to trauma to avoid blood loss, yet it would be fatal if it occurred in an uncontrolled fashion. Accordingly, ...

LUNAC Therapeutics (LUNAC), a UK based drug discovery company focused on the identification and development of advanced anticoagulants with minimal bleeding risk, has announced it has spun out of the ...

Protein S, a well-known anticoagulant protein, keeps the blood flowing in more than one way, discovered researchers at the Salk Institute for Biological Studies. The protein contributes to the ...

Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Direct Oral Anticoagulants (DOACs) Device Market Report 2025" report has been added to ResearchAndMarkets.com's offering. The direct oral anticoagulants ...

Nanomaterial interaction with various components of the coagulation system is determined by the physicochemical properties of the nanoparticle (Figure 2). Below, we will review studies demonstrating ...